NM_004360.5:c.2076T>C

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP2BA1

This summary comes from the ClinGen Evidence Repository: The NM_004360.5(CDH1):c.2076T>C (p.Ala692=) variant has an allele frequency of 0.88894 (88.89%, 22156/24924 alleles, 9856 homozygotes) in the African subpopulation of the gnomAD v2.1.1 cohort (BA1; BP2_Supporting). Therefore, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the CDH1 Variant Curation Expert Panel (Variant Interpretation Guidelines Version 3.1): BA1, BP2_Supporting. LINK:https://erepo.genome.network/evrepo/ui/classification/CA169363/MONDO:0007648/007

Frequency

Genomes: 𝑓 0.70 ( 38079 hom., cov: 30)
Exomes 𝑓: 0.64 ( 297080 hom. )

Consequence

CDH1
NM_004360.5 synonymous

Scores

2

Clinical Significance

Benign reviewed by expert panel B:24

Conservation

PhyloP100: 0.0880

Publications

81 publications found
Variant links:
Genes affected
CDH1 (HGNC:1748): (cadherin 1) This gene encodes a classical cadherin of the cadherin superfamily. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature glycoprotein. This calcium-dependent cell-cell adhesion protein is comprised of five extracellular cadherin repeats, a transmembrane region and a highly conserved cytoplasmic tail. Mutations in this gene are correlated with gastric, breast, colorectal, thyroid and ovarian cancer. Loss of function of this gene is thought to contribute to cancer progression by increasing proliferation, invasion, and/or metastasis. The ectodomain of this protein mediates bacterial adhesion to mammalian cells and the cytoplasmic domain is required for internalization. This gene is present in a gene cluster with other members of the cadherin family on chromosome 16. [provided by RefSeq, Nov 2015]
CDH1 Gene-Disease associations (from GenCC):
  • blepharocheilodontic syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Illumina
  • CDH1-related diffuse gastric and lobular breast cancer syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • hereditary breast carcinoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
  • hereditary diffuse gastric adenocarcinoma
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
  • cleft soft palate
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • orofacial cleft 3
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • blepharocheilodontic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial ovarian cancer
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP2
For more information check the summary or visit ClinGen Evidence Repository.
BA1
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004360.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CDH1
NM_004360.5
MANE Select
c.2076T>Cp.Ala692Ala
synonymous
Exon 13 of 16NP_004351.1A0A0U2ZQU7
CDH1
NM_001317184.2
c.1893T>Cp.Ala631Ala
synonymous
Exon 12 of 15NP_001304113.1P12830-2
CDH1
NM_001317185.2
c.528T>Cp.Ala176Ala
synonymous
Exon 13 of 16NP_001304114.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CDH1
ENST00000261769.10
TSL:1 MANE Select
c.2076T>Cp.Ala692Ala
synonymous
Exon 13 of 16ENSP00000261769.4P12830-1
CDH1
ENST00000422392.6
TSL:1
c.1893T>Cp.Ala631Ala
synonymous
Exon 12 of 15ENSP00000414946.2P12830-2
CDH1
ENST00000562836.5
TSL:1
n.2147T>C
non_coding_transcript_exon
Exon 12 of 15

Frequencies

GnomAD3 genomes
AF:
0.698
AC:
106055
AN:
151870
Hom.:
38020
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.884
Gnomad AMI
AF:
0.595
Gnomad AMR
AF:
0.653
Gnomad ASJ
AF:
0.632
Gnomad EAS
AF:
0.636
Gnomad SAS
AF:
0.656
Gnomad FIN
AF:
0.573
Gnomad MID
AF:
0.668
Gnomad NFE
AF:
0.628
Gnomad OTH
AF:
0.681
GnomAD2 exomes
AF:
0.651
AC:
163615
AN:
251308
AF XY:
0.645
show subpopulations
Gnomad AFR exome
AF:
0.891
Gnomad AMR exome
AF:
0.666
Gnomad ASJ exome
AF:
0.631
Gnomad EAS exome
AF:
0.650
Gnomad FIN exome
AF:
0.592
Gnomad NFE exome
AF:
0.625
Gnomad OTH exome
AF:
0.641
GnomAD4 exome
AF:
0.635
AC:
928592
AN:
1461334
Hom.:
297080
Cov.:
47
AF XY:
0.634
AC XY:
461109
AN XY:
726980
show subpopulations
African (AFR)
AF:
0.895
AC:
29966
AN:
33470
American (AMR)
AF:
0.660
AC:
29540
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.622
AC:
16251
AN:
26134
East Asian (EAS)
AF:
0.607
AC:
24082
AN:
39682
South Asian (SAS)
AF:
0.649
AC:
55966
AN:
86248
European-Finnish (FIN)
AF:
0.596
AC:
31771
AN:
53334
Middle Eastern (MID)
AF:
0.635
AC:
3656
AN:
5756
European-Non Finnish (NFE)
AF:
0.628
AC:
698025
AN:
1111602
Other (OTH)
AF:
0.651
AC:
39335
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
17726
35453
53179
70906
88632
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18706
37412
56118
74824
93530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.699
AC:
106179
AN:
151988
Hom.:
38079
Cov.:
30
AF XY:
0.696
AC XY:
51668
AN XY:
74270
show subpopulations
African (AFR)
AF:
0.884
AC:
36669
AN:
41470
American (AMR)
AF:
0.653
AC:
9958
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
0.632
AC:
2193
AN:
3470
East Asian (EAS)
AF:
0.636
AC:
3282
AN:
5160
South Asian (SAS)
AF:
0.657
AC:
3153
AN:
4802
European-Finnish (FIN)
AF:
0.573
AC:
6039
AN:
10548
Middle Eastern (MID)
AF:
0.663
AC:
195
AN:
294
European-Non Finnish (NFE)
AF:
0.628
AC:
42703
AN:
67972
Other (OTH)
AF:
0.685
AC:
1447
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1557
3114
4672
6229
7786
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
814
1628
2442
3256
4070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.645
Hom.:
59222
Bravo
AF:
0.711
Asia WGS
AF:
0.711
AC:
2471
AN:
3478
EpiCase
AF:
0.620
EpiControl
AF:
0.620

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
8
not specified (8)
-
-
5
Hereditary diffuse gastric adenocarcinoma (5)
-
-
3
Hereditary cancer-predisposing syndrome (3)
-
-
3
not provided (3)
-
-
2
Prostate cancer (2)
-
-
1
Blepharocheilodontic syndrome 1 (1)
-
-
1
CDH1-related diffuse gastric and lobular breast cancer syndrome (1)
-
-
1
Familial cancer of breast (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
6.3
DANN
Benign
0.45
PhyloP100
0.088
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1801552; hg19: chr16-68857441; COSMIC: COSV55728161; COSMIC: COSV55728161; API